Full visible changes usually appear gradually over 2 to 4 weeks
Learn More About Tirzepatide What is Tirzepatide Tirzepatide (brand name Mounjaro for diabetes, Zepbound for weight management) is a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptor agonist the first approved medication to act simultaneously on both incretin hormone receptors
Beyond pancreatic effects, GIP receptor agonism enhances peripheral insulin sensitivity, particularly in adipose tissue, where it promotes healthy white adipose tissue (WAT) expansion, facilitates dietary triglyceride clearance through increased lipoprotein lipase activity and adipose blood flow, and improves lipid buffering capacity [40]
But these changes may bring about the need for increasing your electrolyte intake, to avoid fatigue, reduced exercise performanceOpens in a new tab, brain fog, or other symptoms
Koide, Y., Kato, T., Hayashi, M., Daido, H., Maruyama, T., Ishihara, T., Nishimura, K., Tsunekawa, S., & Yabe, D